9FZI
A new crystal structure of the hPXR-LBD in fusion with an SRC1 co-activator peptide and in complex with SR12813 (P212121 form)
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ESRF BEAMLINE MASSIF-3 |
Synchrotron site | ESRF |
Beamline | MASSIF-3 |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2023-02-09 |
Detector | DECTRIS PILATUS 6M |
Wavelength(s) | 0.967697 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 85.420, 89.030, 106.660 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 44.510 - 2.700 |
R-factor | 0.1958 |
Rwork | 0.194 |
R-free | 0.23710 |
Structure solution method | MOLECULAR REPLACEMENT |
RMSD bond length | 0.009 |
RMSD bond angle | 1.096 |
Data reduction software | XDS |
Data scaling software | XSCALE |
Phasing software | PHENIX |
Refinement software | PHENIX (1.18.2_3874) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 44.510 | 2.770 |
High resolution limit [Å] | 2.700 | 2.700 |
Number of reflections | 22821 | 1689 |
<I/σ(I)> | 11.98 | 2.7 |
Completeness [%] | 99.3 | 99.8 |
Redundancy | 6.8 | 7.2 |
CC(1/2) | 0.998 | 0.851 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION | 277 | 100 mM Imidazole 25 - 30% MPD |